JPRN-UMIN000044411已完成未知
Safety confirmation test of pyrroloquinoline quinone disodium salt-containing food - Safety confirmation test of pyrroloquinoline quinone disodium salt-containing food
Oneness support Co., Ltd.0 个研究点目标入组 23 人开始时间: 2022年6月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 23
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Those with a history of hepatic disease, renal disease, gastrointestinal disease, etc., or any other disease that may affect the results of this study, or those with a history of surgery (2)Those who have undergone hospitalization for treatment due to stroke, subarachnoid hemorrhage, cerebral infarction, cerebral hemorrhage, cerebral contusion, or head trauma (3)Those with abnormal liver and renal function test values (4)Those who have a disease currently being treated (5)Those with food and drug allergies (6)Those with anemia (7)Previous experience of poor or worsened health after giving a blood sample (8)Blood donations 200 mL or more in the month before the trial or have plans for making a blood donation 200 mL or more during the trial period (9)Those who play intense sports and who are on a diet (10)Those who have smoking habits (11)Extremely irregular dietary patterns (12)Those who regularly use health foods (including supplements with antioxidant or blood flow improving effects) for the purpose of decreasing brain function or improving memory loss (13)Those who are taking medicines (antipsychotics, anxiolytics, etc.) that may affect the study (14)Those who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and designated quasi-drugs during the test period (15)Those who continuously take medicines (including OTC and prescription medicines) (16)Heavy drinkers, or those who can't stop drinking from the day before the test until the day (17)Those who have been pregnant or those who have a plan to become pregnant or breast feed during the study period (18)Those who are participating in or will be participating in other clinical trials at the start of this study, and those within 4 weeks after the end (19)Those who judged that examination responsible doctor is not appropriate for this study participation
研究者
相似试验
已完成
不适用
Validation Study of Pyrroloquinoline quinone disodium salt (PQQ 2Na) for Improvement of Brain Function in Healthy AdultsHealthy subjectsJPRN-UMIN000034459HUMA R&D CORP70
已完成
不适用
Safety confirmation test of overdose intake of Okra seed extractHealthy adultJPRN-UMIN000041241Oneness support Co., Ltd.20
已完成
不适用
Safety confirmation test of overdose intake of foods containing Camellia Japonica seed extractHealthy adultJPRN-UMIN000038166Oneness support Co., Ltd.20
已完成
3 期
Monitoring safety of single-low dose primaquine co-administered with ALu in routine healthcare practice: addressing potential implementation challenges and policy options for effective roll outMalariaPACTR202007653561223Ifakara Health Institute600
已完成
不适用
Safety confirmation test of long-term intake of Okra seed extractHealthy adultJPRN-UMIN000041242Oneness support Co., Ltd.20